Our Lab
Our laboratory uses a state-of-the-art functional genomics approach for studying human disease and identify genetic factors that can be exploited as therapeutic targets or utilized as biomarkers for predicting patient outcome.
What Are We Up To?
Areas of active investigation include:
1) Development of novel small molecules inhibitors for the treatment of metastatic breast cancer to the lung
2) The generation of novel gene editing technology for curing of lung adenocarcinoma
3) Identifying novel genomic elements in neurofibromatosis that can be targeted for suppressing tumor growth in individual patients: a precision medicine approach for curing neurofibromatosis.
1) Development of novel small molecules inhibitors for the treatment of metastatic breast cancer to the lung
2) The generation of novel gene editing technology for curing of lung adenocarcinoma
3) Identifying novel genomic elements in neurofibromatosis that can be targeted for suppressing tumor growth in individual patients: a precision medicine approach for curing neurofibromatosis.